New Treatment Strategy Targeting Galectin-1 against Thyroid Cancer

Although the overall survival rate of papillary or follicular thyroid cancers is good, anaplastic carcinomas and radio iodine refractory cancers remain a significant therapeutic challenge. Galectin-1 (Gal-1) is overexpressed in tumor cells and tumor-associated endothelial cells, and is broadly impli...

Descripción completa

Detalles Bibliográficos
Autores principales: Gheysen, Laetitia, Soumoy, Laura, Trelcat, Anne, Verset, Laurine, Journe, Fabrice, Saussez, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147933/
https://www.ncbi.nlm.nih.gov/pubmed/34063063
http://dx.doi.org/10.3390/cells10051112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147933/
https://www.ncbi.nlm.nih.gov/pubmed/34063063
http://dx.doi.org/10.3390/cells10051112

Ejemplares similares